Abstract
Background. Patients with bone metastasis of gastric cancer occasionally experience disseminated intravascular coagulation (DIC), with a very poor prognosis.
Methods. We treated 18 gastric cancer patients with bone metastasis with sequential methotrexate and 5-fluorouracil (sequential MTX/5-FU therapy). The treatment schedule comprised weekly administration of methotrexate (MTX; 100 mg/m2, i.v. bolus) followed by 5-fluorouracil (5-FU; 600 mg/m2, i.v. bolus) after an interval of 3 h. Calcium leucovorin (10 mg/m2, p.o. or i.v.) was administered six times, every 6 h starting 24 h after the administration of MTX.
Results. In 11 patients with measurable metastatic lesions, the response rate was 64% (7/11). Nine patients (50%) had DIC before the initiation of chemotherapy, and 8 of them (89%) recovered from it. Two of these 9 patients (22%) survived for more than 1 year. The median survival times for all patients and for the 9 with DIC were 186 and 113 days, respectively. Grade 4 leukopenia was observed in 3 patients (17%). No treatment-related deaths occurred.
Conclusion. Sequential MTX/5-FU therapy may have palliative potential and may be a feasible treatment for gastric cancer patients with bone metastasis with or without DIC.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Author information
Authors and Affiliations
Additional information
Received: December 10, 1999 / Accepted: January 28, 2000
Rights and permissions
About this article
Cite this article
Hironaka, Si., Boku, N., Ohtsu, A. et al. Sequential methotrexate and 5-fluorouracil therapy for gastric cancer patients with bone metastasis. Gastric Cancer 3, 19–23 (2000). https://doi.org/10.1007/PL00011684
Issue Date:
DOI: https://doi.org/10.1007/PL00011684